limit traction three year post merger
growth like remain mute year full pmi deliveri remain challeng
dormakaba set bar rel low fy expect strong
perform industri peer growth margin north america
phase-out servic busi third parti compon area sale
impact year post addit challeng deliv growth
compani see cost synergi deliv remain
materi next two year mind forecast
ebitda margin improv last year
would still consider target target conserv
regard plan benefit procur oper leverag product mix
trim ep estim next three year put
consensu believ oper challeng us well
germani remain drag year lack see materi synergi
combin product offer sinc merger sell reiter
fy-guid low bar still beat expect
expect compani come low end ebitda margin target
ubs would impli margin improv larg
cost synergi well product re-loc standard product germani
china org sale growth rage ubs would half assa
org growth guidanc year
limit motiv germani us
given current challeng pmi phase manag state would
execut substanti acquisit germani us year continu
expect bolt-on acquisit market particularli latam asia
critic enough drive equiti stori
valuat dcf-base pt lower previous
lower dcf-base pt termin assumpt
includ termin sale growth ebit margin wacc
unchang pt reduct driven lower estim forecast period well
somewhat lower bridg period assumpt
trade data key metric
compani account thomson reuter ub estim metric mark ub analyst adjust appli valuat base averag share price year base
share price dec gmt
report prepar ub limit analyst certif requir disclosur begin page
ub seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
profit tax
profit tax
net chang work capit
net cash flow
flow inc /dec net debt
balanc sheet inc /dec net debt
compani account ub estim ub metric use report figur adjust ub ep ub dilut calcul use ub net incom ad back depreci
buy minor
revenu divis chfm
ebit ub divis chfm
compani account ub estim ub metric use report figur adjust ub analyst
valuat method risk statement
price target dcf-base
dormakaba lock sale go exist build cyclic
rel low nevertheless major chang construct activ could affect
earn apart overal econom activ risk invest case
includ potenti underestim impact oper leverag failur
adequ forecast degre cyclic busi usd/chf
exchang rate experienc greater declin anticip merger
kaba dorma could pose integr execut risk
oper point view depend key personnel licenc
patent combin depend technolog expertis short
life cycl electron product pose intern risk compani
